Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

BACKGROUND: Ofatumumab, a fully human anti-CD20 monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis (RMS), binds to a unique conformational epitope, thereby depleting B cells very efficiently and allowing subcutaneous administration at lower doses. OBJECTIVES: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Huixin, Graham, Gordon, David, Olivier J., Kahn, Joseph M., Savelieva, Marina, Pigeolet, Etienne, Das Gupta, Ayan, Pingili, Ratnakar, Willi, Roman, Ramanathan, Krishnan, Kieseier, Bernd C., Häring, Dieter A., Bagger, Morten, Soelberg Sørensen, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927028/
https://www.ncbi.nlm.nih.gov/pubmed/35233753
http://dx.doi.org/10.1007/s40263-021-00895-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927028/
https://www.ncbi.nlm.nih.gov/pubmed/35233753
http://dx.doi.org/10.1007/s40263-021-00895-w

Ejemplares similares